Britain says 31.9 million people given COVID vaccination
Reuters
Published Apr 09, 2021 16:31
Updated Apr 09, 2021 17:15
LONDON (Reuters) - Britain said on Friday it had given 545,511 COVID vaccine doses on April 8, the highest daily total since April 1, while a further 60 people had died within 28 days of a positive test for the disease, raising this death toll to 127,040.
The number of people in Britain who have received two vaccine doses rose to 6.541 million and the number who have received at least one dose increased to 31.903 million, more than 60% of the adult population according to government daily figures.
Some 3,150 people were reported to have tested positive for COVID-19 in the daily data published on April 9, taking the number of cases over the past 7 days to 19,804, 32% lower than the week before.
Health officials also said they had revised down some cumulative data after positive cases detected by rapid lateral flow tests later turned out to be negative. In 8,010 cases the lateral flow tests were followed within 3 days by a gold-standard PCR test and found to be negative.
Cheaper and faster lateral flow tests are increasingly being used to reopen the economy and some scientists have raised questions about the volume of false positives they can produce.
Public Health England has said that anyone receiving a positive test on a lateral flow device should follow it with a PCR test to be sure.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.